Effect of oral clodronate on bone pain

Inkeri Elomaa, Timo Kylmälä, Teuvo L.J. Tammela, +8

International Urology and Nephrology

Bone DiseaseBone HealthHealth SciencesPain MedicinePain Management +6

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer

Timo Kylmälä, TLJ Tammela, Leila Risteli, +3

British Journal of Cancer

UrologyGenitourinary CancerMedicinePrognostic ValuePathology +4

Concomitant i.v. and oral clodronate in the relief of bone pain – a double-blind placebo-controlled study in patients with prostate cancer

Timo Kylmälä, T. Taube, TLJ Tammela, +3

British Journal of Cancer

Bone DiseaseUrologyBone HealthPain MedicineMedicine +7

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group

Timo Kylmälä, Teuvo L.J. Tammela, Leila Risteli, +3

European Journal of Cancer

Bone DiseaseType 1UrologyBone HealthMedicine +9

The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.

Timo Kylmälä, Teuvo L.J. Tammela, T. Sam Lindholm, +1

PubMed

Bone ResorptionPain MedicineOsteosclerotic MetastasesPharmacotherapyOsteoporosis +16

Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years

Peter Iversen, Jan‐Erik Johansson, Pär Lodding, +7

Scandinavian Journal of Urology and Nephrology

Early Prostate CancerUrologyOncologySurgical OncologyCancer Epidemiology +12

Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer

Markku J. Leskinen, Kaisu Rantakokko‐Jalava, Raija Manninen, +4

The Prostate

Treatment of Postoperative Male Urinary Incontinence Using Transurethral Macroplastique Injections

Timo Kylmälä, Hanna Tainio, Mika Raitanen, +1

Journal of Endourology

The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study

T. Taube, Timo Kylmälä, Christel Lamberg‐Allardt, +2

European Journal of Cancer

Bone DiseaseMetastatic Prostate CancerUrologyBone HealthMedicine +7

Suspicious Urine Cytology (Class III) in Patients with Bladder Cancer: Should it be Considered as Negative or Positive?

Mika Raitanen, Risto Aine, Eevi Kaasinen, +4

Scandinavian Journal of Urology and Nephrology